According to WP, the incidence of myocarditis in those who receive the vaccine from this manufacturer may be 2.5 times higher than after the Pfizer-BioNTech vaccine.
Employees of the American health care system are checking information that vaccination with the Moderna drug may be associated with inflammation of the heart muscle – myocarditis – in people under 30 years of age in more cases than previously thought. This was reported by The Washington Post.
The study of reports of side effects of the vaccine also affected the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). “We can say that the FDA is absolutely committed to verifying the data as it becomes available. Earlier, we reported on the connection of myocarditis and vaccines against COVID-19. If the new information changes the risk-benefit ratio, we will notify the public accordingly,” a representative of the FDA commented on the situation.
One of the newspaper sources reported that the data provided by the government of Canada show that the incidence of myocarditis in those who receive the Moderna vaccine may be 2.5 times higher than after the Pfizer-BioNTech vaccine.
Moderna did not respond to a request for comment.